Species: Lactobacillus crispatus (HMT-0817) Primary Body Site: Vaginal
Download Options
LINKS: Ecology Home
| HMT-0817: [Body Sites Data]
[Taxon Description]
| Life Page: Lactobacillus crispatus
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.25 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 1.19 | 0.06 | 0.01 | 2.56 | 68.83 | 57.20 | 51.81 | 0.01 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.56 | 24.21 | 0.01 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0.01 | 0 | 0 | 0 | 0.13 | 0.06 | 0.02 | 2.56 | 97.52 | 96.99 | 97.78 | 0 |
| Stdev | 0.01 | 4.87 | 0.01 | 0.02 | 0.01 | 0 | 0 | 0 | 0 | 0.03 | 8.07 | 0.25 | 0.02 | 0 | 46.55 | 47.63 | 44.16 | 0.10 |
| Prev(%) | 0 | 0.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.24 | 4.62 | 8.70 | 3.33 | 100.00 | 75.00 | 62.50 | 64.89 | 0.53 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.01 | 0 | 0.07 | 0 | 0.04 | 0 | 0 | 0.06 | 0.33 | 0.03 | 0.04 | 0.34 | 0.46 | 42.18 | 45.02 | 46.15 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.04 | 0 | 0.06 | 0 | 0.11 | 0 | 0 | 0.02 | 0.09 | 0.05 | 0.05 | 0.78 | 1.55 | 96.34 | 97.95 | 99.05 | 0 |
| Stdev | 0 | 0.03 | 0 | 0.54 | 0 | 0.13 | 0 | 0 | 0.51 | 3.45 | 0.14 | 0.24 | 1.20 | 1.38 | 43.06 | 45.26 | 46.19 | 0 |
| Prev(%) | 0 | 21.85 | 0 | 31.51 | 0 | 27.69 | 0 | 0 | 20.64 | 27.00 | 21.84 | 18.70 | 29.89 | 27.65 | 70.42 | 67.57 | 67.11 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Neither HMT-529 nor HMT-817 were present singularly so these reads were split evenly at these sites (ANA,LAF,RRC,SUBP,SUPP).
Because HMT-529 is not present individually, all equidistant reads were assigned to HMT-817 at these sites (LRC,MVA,PFO,RAF,VIN).
Neither HMT-529 nor HMT-817 were present singularly so these reads were split evenly at these sites (ANA,LAF,RRC,SUBP,SUPP).
Because HMT-529 is not present individually, all equidistant reads were assigned to HMT-817 at these sites (LRC,MVA,PFO,RAF,VIN).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.23 | 0.30 | 0.26 | 0.50 | 0.60 | 44.45 | 50.25 | 50.46 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.10 | 0.12 | 0.06 | 0.56 | 1.44 | 97.46 | 99.14 | 99.62 | 0 |
| Stdev | 0.08 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.40 | 2.49 | 2.83 | 3.07 | 1.74 | 42.59 | 45.38 | 45.91 | 0 |
| Prev(%) | 15.56 | 14.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.89 | 21.66 | 23.15 | 40.00 | 42.00 | 73.56 | 68.85 | 68.59 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| Prev(%) | 1.35 | 0 | 2.33 | 5.71 | 10.71 | 4.00 | 6.06 | 0 | 0 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.25 | 0 | 0.10 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.43 | 0.05 | 0.04 | 3.72 | 54.91 | 57.03 | 47.60 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.72 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 3.72 | 99.14 | 98.50 | 99.82 | 0 |
| Stdev | 0 | 4.98 | 0.01 | 0.39 | 0.19 | 0 | 0 | 0 | 0 | 0.03 | 5.15 | 0.23 | 0.18 | 0 | 41.83 | 44.80 | 46.48 | 0.06 |
| Prev(%) | 0 | 1.01 | 4.17 | 11.77 | 1.86 | 0 | 0 | 0 | 4.00 | 0.23 | 5.86 | 8.33 | 15.63 | 100.00 | 81.82 | 71.43 | 58.59 | 1.46 |
